
AI: Nestlé develops products for GLP-1 weight-loss drug users
Nestlé is seeking to turn the rise of GLP-1 (glucagon-like peptide-1 receptor agonist) weight-loss drugs from a threat into an opportunity, using artificial intelligence (AI) and nutritional science to develop products for the millions of consumers taking medicines such as Ozempic and Wegovy, ESM Magazine reports, citing Reuters. The rapid


